FREE EDUCATIONAL WEBINAR
16 April 2026, 13:00 - 14:00 PM CET (*)
Pharma companies invest heavily in congress participation, yet many teams struggle to translate that investment into sustained HCP engagement and measurable impact. Too often, congresses are treated as high-visibility events rather than strategic milestones within a longer engagement journey.
In this educational webinar, Yacin Marzouki introduces the core thinking behind the new CELforPharma course Maximising Congress Impact in Pharma. He will explore why many congress strategies underperform and how shifting from “event execution” to a structured 12-week engagement model can significantly improve results.
Why attend:
Understand why many congress investments fail to deliver lasting impact
Recognise the engagement gap between pharma teams and HCP expectations
Get introduced to a structured approach to pre-, during-, and post-congress engagement
Gain practical insights you can immediately reflect on within your own organisation
Benchmark your current congress approach against live industry feedback
About the expert:
Yacin Marzouki, expert trainer of Maximising Congress Impact in Pharma, is the CEO of Biondhealth, a boutique consultancy specialising in helping pharma organisations move from channel execution to customer-focused, value-driven engagement systems.
He has led omnichannel and congress strategy for major global scientific meetings, helping global and local teams translate scientific intent into coordinated, measurable engagement before, during, and after the event.
Recognised as a trusted industry voice, Yacin is regularly invited to speak at leading international pharma forums and events.
Passionate about challenging traditional promotional models, Yacin focuses on building engagement approaches that create lasting value for healthcare professionals – before, during, and long after key brand moments such as congresses.
(*) If you cannot attend the webinar, please note that a recorded playback will be sent to all registrants after the webinar.